Corvia Medical Garners CE Mark for InterAtrial Shunt Device

Corvia Medical has secured CE Mark approval for an InterAtrial shunt device designed to treat diastolic heart failure.

Results from a CE Mark study show patients experienced “significantly fewer” heart failure symptoms and also were able to exercise for longer periods of time.

The device, also referred to as the Corvia atrial decompression system, is the first transcatheter device with this indication in the EU, according to the company. — Anisa Jibrell